Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PCSK9 Polymorphism and Risk of Mechanical Complications Following Acute Myocardial Infarction

NCT05503095 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT05503095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05503095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PCSK9 Polymorphism and Risk of Mechanical Complications Following Acute Myocardial Infarction
Lead sponsor
Maastricht University Medical Center
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2022
Completion date
May 31, 2024
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gene polymorphism, post-infarction heart rupture